<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>weightregain on Gloucestershire Daily</title><link>https://gloucestershiredaily.co.uk/tags/weightregain/</link><description>Recent content in weightregain on Gloucestershire Daily</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><lastBuildDate>Thu, 30 Apr 2026 02:55:00 +0000</lastBuildDate><atom:link href="https://gloucestershiredaily.co.uk/tags/weightregain/index.xml" rel="self" type="application/rss+xml"/><item><title>Ozempic and Wegovy Users Face Weight Regain Warning Within 18 Months</title><link>https://gloucestershiredaily.co.uk/ozempic-and-wegovy-users-face-weight-regain-warning-within-18-months/</link><pubDate>Thu, 30 Apr 2026 02:55:00 +0000</pubDate><guid>https://gloucestershiredaily.co.uk/ozempic-and-wegovy-users-face-weight-regain-warning-within-18-months/</guid><description>Recent research reveals that individuals discontinuing GLP-1 medications such as Ozempic and Wegovy can expect to regain the weight they lost within approximately 18 months. An analysis of 37 previous studies involving 9,000 participants, published in the British Medical Journal (BMJ), highlights that weight rebound after stopping these drugs happens much faster than after behavioural weight loss methods like diet and exercise.
GLP-1 medications, originally developed to treat Type 2 diabetes, have become widely used for weight management by suppressing appetite, slowing digestion, and prolonging feelings of fullness.</description></item></channel></rss>